Consumer Reports reviewing top drugs
685978
Consumers Union, publishers of Consumer Reports, launched a &quot;Best Buy&quot; Web site for medications Thursday. In a telephone news conference from Washington, DC, CU announced that three classes of drugs were already tested and posted.
214469
Medicines watchdogs are reviewing safety data for an entire class of drugs taken by millions of patients with arthritis and severe pain after the worldwide withdrawal of Merck&#39;s Vioxx last week.
390330
WASHINGTON Consumer Reports has launched its free Best Buy Drugs Web site, rating what it says are the best medicines at the lowest prices.
440274
Congress has been investigating the FDA&#39;s decisions in both the Vioxx and antidepressant cases. The probes have focused on agency reviewers who warned about potential problems but claimed their research was ignored or suppressed by other officials.
205695
The US Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck &amp; Co.
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
551992
Medicines used by millions of Americans to relieve aches and pains will come under intense scrutiny starting Wednesday as U.S. scientists scour dozens of studies to determine if the drugs risk damaging the heart like Merck & Co. Inc.'s withdrawn arthritis pill Vioxx.
157316
A consumer group and 35 doctors and scientists asked the federal government Thursday to convene an independent review of the science that led to new guidelines urging wider use of cholesterol-lowering statin drugs.
238203
The publisher of Consumer Reports launched a free Web site Thursday to do for prescription drugs what it has already done for cars, refrigerators and other gadgets: rate them on safety, effectiveness and cost.
143996
For patients weary of scary headlines about popular treatments like the heart drug Vytorin, a new report issued on Thursday by U.S. Institute of Medicine may offer welcome relief.
130259
SOME of Britainâs most popular medicines are to be reviewed by drug regulators after claims by an American scientist that they pose severe risks to patients and should not be prescribed.
158825
Exelixis' partner requests an early review of its No. 2 drug.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
721361
A vast majority of patients and doctors would surely agree that pharmaceutical companies ought to reveal the results of clinical trials that suggest that their drugs don&#39;t work or may even be harmful.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
336236
U.S. regulators said on Friday they would review a study showing a Merck and Schering-Plough cholesterol drug worked no better than a generic in preventing the build-up of arterial plaque.
515893
Pushing more of the cost of  prescription drugs onto consumers causes patients to cut back,  sometimes with adverse health consequences, according to a  review of two decades worth of studies published on Tuesday.